Effect of exercise versus control group on cardiac inflammatory factors in patients with liver disease

Effect of exercise versus control group on cardiac inflammatory factors in patients with liver disease: a randomized clinical trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N444

Enrollment

Registered

2022-10-12

Start date

2022-10-23

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver disease. Liver disorders in diseases classified elsewhere

Interventions

Intervention 1: Intervention group: Routine care of liver patients in addition to resistance exercises (including squat, chest press, barbell launch, front cable pull bar, abdominal crunch, barbell un

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age 18 to 65 years Liver failure

Exclusion criteria

Exclusion criteria: Diabetes, asthma or cardiovascular diseases Using tobacco, drugs, alcohol, or stimulants

Design outcomes

Primary

Measure	Time frame
Cardiac inflammatory factors. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: By laboratory tests.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Fili

Islamic Azad University

hmdfl971@gmail.com+98 81 3448 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026